Deregulated c-fos expression interferes with normal bone development in transgenic mice

Transgenic mice were generated expressing c-fos genes under the control of the human metallothionein promoter. Although high levels of c-fos messenger RNA were detectable in a variety of tissues, deregulated c-fos expression specifically interferes with normal bone development without inducing malignant tumours.

[1]  T. Jenuwein,et al.  Extended life span and tumorigenicity of nonestablished mouse connective tissue cells transformed by the fos oncogene of FBR-MuSV , 1985, Cell.

[2]  M. Finkel,et al.  Experimental Induction of Osteosarcomas , 1968 .

[3]  M. Karin,et al.  Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene , 1984, Nature.

[4]  E. Wagner,et al.  Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes , 1984, Nature.

[5]  I. Verma.  Proto-oncogene fos: a multifaceted gene , 1986 .

[6]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[7]  Jonathan A. Cooper,et al.  Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein , 1984, Nature.

[8]  H. Varmus,et al.  Expression of v-src and chicken c-src in rat cells demonstrates qualitative differences between pp60 v-src and pp60 c-src , 1984, Cell.

[9]  H. Herbst,et al.  Evidence that expression of c‐fos protein in amnion cells is regulated by external signals. , 1986, The EMBO journal.

[10]  J. Rossant,et al.  Experimental approaches to mammalian embryonic development: Molecular and biochemical aspects , 1987 .

[11]  T. Curran,et al.  Induction of c-fos gene and protein by growth factors precedes activation of c-myc , 1984, Nature.

[12]  R. Müller.  Cellular and viral fos genes: structure, regulation of expression and biological properties of their encoded products. , 1986, Biochimica et biophysica acta.

[13]  T. Curran,et al.  c-fos protein can induce cellular transformation: A novel mechanism of activation of a cellular oncogene , 1984, Cell.

[14]  E. Wagner,et al.  Analysis of the differentiation‐promoting potential of inducible c‐fos genes introduced into embryonal carcinoma cells. , 1985, The EMBO journal.

[15]  Michael E. Greenberg,et al.  Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene , 1984, Nature.

[16]  I. Verma,et al.  Expression of c‐onc genes: c‐fos transcripts accumulate to high levels during development of mouse placenta, yolk sac and amnion. , 1983, The EMBO journal.

[17]  R. Palmiter,et al.  Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs , 1981, Cell.

[18]  H. Varmus,et al.  Molecular biology of tumor viruses. RNA tumor viruses. , 1982 .

[19]  C. H. Price,et al.  FBJ Virus-induced Tumours in Mice , 1972, British Journal of Cancer.

[20]  D. Spandidos,et al.  Malignant transformation of early passage rodent cells by a single mutated human oncogene , 1984, Nature.

[21]  R. Müller.  Proto-oncogenes and differentiation , 1986 .

[22]  D. Hanahan,et al.  Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. , 1985, Nature.

[23]  R. Müller,et al.  Differential expression of c‐fos in hematopoietic cells: correlation with differentiation of monomyelocytic cells in vitro. , 1984, The EMBO journal.

[24]  D. Hanahan,et al.  Bovine papillomavirus genome elicits skin tumours in transgenic mice , 1986, Nature.

[25]  D. Melton,et al.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. , 1984, Nucleic acids research.

[26]  D. Hanahan.  Oncogenesis in Transgenic Mice , 1986 .

[27]  G. Bourne,et al.  The biochemistry and physiology of bone , 1956 .

[28]  J. Ward,et al.  Histogenesis and Morphology of periosteal sarcomas induced by FBJ virus in NIH Swiss mice. , 1976, Cancer research.

[29]  R. Palmiter,et al.  Transgenic mice harboring SV40 t-antigen genes develop characteristic brain tumors , 1984, Cell.

[30]  M. Finkel,et al.  Virus Induction of osteosarcomas in Mice , 1966, Science.

[31]  H. Varmus.  The molecular genetics of cellular oncogenes. , 1984, Annual review of genetics.

[32]  P. Leder,et al.  Consequences of widespread deregulation of the c-myc gene in transgenic mice: Multiple neoplasms and normal development , 1986, Cell.

[33]  A. W. Harris,et al.  The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice , 1986, Cell.

[34]  T. Hunter.  Oncogenes and growth control , 1985 .

[35]  P. Leder,et al.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes , 1984, Cell.

[36]  R. Palmiter,et al.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice , 1985, Nature.

[37]  Richard Treisman,et al.  Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′ element and c-fos 3′ sequences , 1985, Cell.

[38]  T. Curran,et al.  Removal of a 67-base-pair sequence in the noncoding region of protooncogene fos converts it to a transforming gene. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Shaw,et al.  A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.